Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation‐negative breast cancer but not in other malignancies

BACKGROUND: BARD1 was originally identified as a BRCA1‐interacting protein but has also been described in tumour‐suppressive functions independent of BRCA1. Several studies have indicated that the BARD1 gene is a potential target for germline changes predisposing to breast and ovarian cancer. The C‐...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Karppinen, S‐M, Barkardottir, R B, Backenhorn, K, Sydenham, T, Syrjäkoski, K, Schleutker, J, Ikonen, T, Pylkäs, K, Rapakko, K, Erkko, H, Johannesdottir, G, Gerdes, A‐M, Thomassen, M, Agnarsson, B A, Grip, M, Kallioniemi, A, Kere, J, Aaltonen, L A, Arason, A, Møller, P, Kruse, T A, Borg, Å, Winqvist, R
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563183/
https://ncbi.nlm.nih.gov/pubmed/16825437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2006.041731
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars